American Bio Medica (ABMC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABMC Annual Balance Sheets →
Looking at balance sheet data from American Bio Medica through Mar 31 2022 provides insight into Mar 31 2023's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Accounts receivable0.09
Inventories0.00
Other Current Assets0.50
Prepaid Expense And Other Assets Current0.00
Total Current Assets0.66
Equipment/Property/Plant Net0.00
Income Taxes Receivable PR0.20
Other Assets, Noncurrent0.00
Retention Fund Receivable Asset Sale0.30
Operating Lease Right Of Use Asset0.00
Total Assets0.66
Liabilities
Accounts Payable, Current AC0.57
Employee-related Liabilities, Current AC0.03
Line of Credit, Current LO0.00
Other Liabilities, Current0.51
Total Current Liabilities1.12
Other Long-term Debt, Current OT0.00
Total Long-term Debt0.00
RightOfUseLiabilitiesOperatingLeasesnoncurrent0.00
Right Of Use Liabilities Operating Leases Current0.00
Total Liabilities1.12
Stockholders' Equity
Common Stock Value0.48
Additional Paid In Capital Common Stock22.40
Retained Earnings / Accumulated Deficit-23.34
Other Equity0.00
Common Stockholder's Equity-0.46
Total Stockholder's Equity-0.46
Liabilities & Stockholder's Equity0.66
4 historic quarters locked

Sign in to unlock the full American Bio Medica balance sheet history.

About American Bio Medica Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001654954-23-007911

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.